Logo image of CHR-DB-B.CA

CHORUS AVIATION INC (CHR-DB-B.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:CHR-DB-B - CA17040TAE25

100.4 CAD
+0.39 (+0.39%)
Last: 9/24/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CHR-DB-B. CHR-DB-B was compared to 7 industry peers in the Passenger Airlines industry. Both the profitability and the financial health of CHR-DB-B get a neutral evaluation. Nothing too spectacular is happening here. CHR-DB-B is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CHR-DB-B was profitable.
CHR-DB-B had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CHR-DB-B reported negative net income in multiple years.
CHR-DB-B had a positive operating cash flow in each of the past 5 years.
CHR-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.91%, CHR-DB-B is doing worse than 75.00% of the companies in the same industry.
CHR-DB-B has a worse Return On Equity (-4.82%) than 62.50% of its industry peers.
CHR-DB-B's Return On Invested Capital of 6.54% is amongst the best of the industry. CHR-DB-B outperforms 87.50% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CHR-DB-B is in line with the industry average of 5.26%.
The 3 year average ROIC (5.30%) for CHR-DB-B is below the current ROIC(6.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.91%
ROE -4.82%
ROIC 6.54%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR-DB-B.CA Yearly ROA, ROE, ROICCHR-DB-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

Looking at the Operating Margin, with a value of 6.87%, CHR-DB-B is in line with its industry, outperforming 50.00% of the companies in the same industry.
CHR-DB-B's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 65.48%, CHR-DB-B belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
In the last couple of years the Gross Margin of CHR-DB-B has declined.
Industry RankSector Rank
OM 6.87%
PM (TTM) N/A
GM 65.48%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR-DB-B.CA Yearly Profit, Operating, Gross MarginsCHR-DB-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHR-DB-B is destroying value.
CHR-DB-B has less shares outstanding than it did 1 year ago.
CHR-DB-B has more shares outstanding than it did 5 years ago.
CHR-DB-B has a better debt/assets ratio than last year.
CHR-DB-B.CA Yearly Shares OutstandingCHR-DB-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR-DB-B.CA Yearly Total Debt VS Total AssetsCHR-DB-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 2.38 indicates that CHR-DB-B is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CHR-DB-B (2.38) is better than 87.50% of its industry peers.
The Debt to FCF ratio of CHR-DB-B is 7.89, which is on the high side as it means it would take CHR-DB-B, 7.89 years of fcf income to pay off all of its debts.
CHR-DB-B's Debt to FCF ratio of 7.89 is amongst the best of the industry. CHR-DB-B outperforms 87.50% of its industry peers.
CHR-DB-B has a Debt/Equity ratio of 0.54. This is a neutral value indicating CHR-DB-B is somewhat dependend on debt financing.
CHR-DB-B has a better Debt to Equity ratio (0.54) than 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.89
Altman-Z 2.38
ROIC/WACC0.75
WACC8.76%
CHR-DB-B.CA Yearly LT Debt VS Equity VS FCFCHR-DB-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

CHR-DB-B has a Current Ratio of 1.14. This is a normal value and indicates that CHR-DB-B is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CHR-DB-B (1.14) is worse than 62.50% of its industry peers.
A Quick Ratio of 0.61 indicates that CHR-DB-B may have some problems paying its short term obligations.
With a Quick ratio value of 0.61, CHR-DB-B is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.61
CHR-DB-B.CA Yearly Current Assets VS Current LiabilitesCHR-DB-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

CHR-DB-B shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.57%, which is quite impressive.
Measured over the past years, CHR-DB-B shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -19.03% on average per year.
The Revenue for CHR-DB-B has decreased by -13.36% in the past year. This is quite bad
Measured over the past years, CHR-DB-B shows a small growth in Revenue. The Revenue has been growing by 0.56% on average per year.
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%

3.2 Future

Based on estimates for the next years, CHR-DB-B will show a small growth in Earnings Per Share. The EPS will grow by 1.21% on average per year.
The Revenue is expected to decrease by -5.14% on average over the next years.
EPS Next Y55.31%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue Next Year-4.85%
Revenue Next 2Y-3.49%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CHR-DB-B.CA Yearly Revenue VS EstimatesCHR-DB-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR-DB-B.CA Yearly EPS VS EstimatesCHR-DB-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 44.62, CHR-DB-B can be considered very expensive at the moment.
62.50% of the companies in the same industry are cheaper than CHR-DB-B, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CHR-DB-B to the average of the S&P500 Index (26.46), we can say CHR-DB-B is valued expensively.
With a Price/Forward Earnings ratio of 52.09, CHR-DB-B can be considered very expensive at the moment.
CHR-DB-B's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CHR-DB-B is more expensive than 62.50% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CHR-DB-B to the average of the S&P500 Index (36.10), we can say CHR-DB-B is valued slightly more expensively.
Industry RankSector Rank
PE 44.62
Fwd PE 52.09
CHR-DB-B.CA Price Earnings VS Forward Price EarningsCHR-DB-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHR-DB-B is valued a bit more expensive than the industry average as 75.00% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHR-DB-B indicates a somewhat cheap valuation: CHR-DB-B is cheaper than 62.50% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 52.76
EV/EBITDA 13.62
CHR-DB-B.CA Per share dataCHR-DB-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

CHR-DB-B's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.81
PEG (5Y)N/A
EPS Next 2Y12.98%
EPS Next 3Y1.21%

2

5. Dividend

5.1 Amount

CHR-DB-B has a Yearly Dividend Yield of 1.42%.
CHR-DB-B's Dividend Yield is a higher than the industry average which is at 2.47.
Compared to the average S&P500 Dividend Yield of 2.32, CHR-DB-B is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.42%

5.2 History

On average, the dividend of CHR-DB-B grows each year by 21.58%, which is quite nice.
CHR-DB-B is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

CHR-DB-B has negative earnings and hence a negative payout ratio. The dividend may be in danger.
CHR-DB-B's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-34.57%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
CHR-DB-B.CA Yearly Income VS Free CF VS DividendCHR-DB-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CHORUS AVIATION INC

TSX:CHR-DB-B (9/24/2025, 7:00:00 PM)

100.4

+0.39 (+0.39%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners3.2%
Inst Owner ChangeN/A
Ins Owners1.35%
Ins Owner ChangeN/A
Market Cap2.57B
Revenue(TTM)1.37B
Net Income(TTM)-25.87M
Analysts78
Price Target133.9 (33.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.42%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-34.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.45%
Min EPS beat(2)3.87%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)62.09%
Min EPS beat(4)3.87%
Max EPS beat(4)207.96%
EPS beat(8)5
Avg EPS beat(8)11.1%
EPS beat(12)6
Avg EPS beat(12)4.98%
EPS beat(16)8
Avg EPS beat(16)3.11%
Revenue beat(2)0
Avg Revenue beat(2)-6.13%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-3.95%
Revenue beat(4)0
Avg Revenue beat(4)-6%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)3
Avg Revenue beat(8)-2.48%
Revenue beat(12)5
Avg Revenue beat(12)-1.45%
Revenue beat(16)8
Avg Revenue beat(16)1.16%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-1.03%
EPS NQ rev (3m)-5.64%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.29%
Revenue NQ rev (1m)-0.89%
Revenue NQ rev (3m)-2.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.63%
Valuation
Industry RankSector Rank
PE 44.62
Fwd PE 52.09
P/S 1.88
P/FCF 52.76
P/OCF 30.38
P/B 4.78
P/tB 4.86
EV/EBITDA 13.62
EPS(TTM)2.25
EY2.24%
EPS(NY)1.93
Fwd EY1.92%
FCF(TTM)1.9
FCFY1.9%
OCF(TTM)3.3
OCFY3.29%
SpS53.45
BVpS20.99
TBVpS20.65
PEG (NY)0.81
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.91%
ROE -4.82%
ROCE 8.82%
ROIC 6.54%
ROICexc 6.9%
ROICexgc 6.96%
OM 6.87%
PM (TTM) N/A
GM 65.48%
FCFM 3.56%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexgc growth 3Y33.52%
ROICexgc growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.89
Debt/EBITDA 1.36
Cap/Depr 30.21%
Cap/Sales 2.62%
Interest Coverage 2.06
Cash Conversion 39.75%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.61
Altman-Z 2.38
F-Score5
WACC8.76%
ROIC/WACC0.75
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
EPS Next Y55.31%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%
Revenue Next Year-4.85%
Revenue Next 2Y-3.49%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A
EBIT growth 1Y-53.02%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year86.18%
EBIT Next 3Y12.53%
EBIT Next 5YN/A
FCF growth 1Y-79.47%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-70.44%
OCF growth 3Y12.73%
OCF growth 5Y0.25%

CHORUS AVIATION INC / CHR-DB-B.CA FAQ

Can you provide the ChartMill fundamental rating for CHORUS AVIATION INC?

ChartMill assigns a fundamental rating of 4 / 10 to CHR-DB-B.CA.


What is the valuation status of CHORUS AVIATION INC (CHR-DB-B.CA) stock?

ChartMill assigns a valuation rating of 2 / 10 to CHORUS AVIATION INC (CHR-DB-B.CA). This can be considered as Overvalued.


Can you provide the profitability details for CHORUS AVIATION INC?

CHORUS AVIATION INC (CHR-DB-B.CA) has a profitability rating of 4 / 10.


Can you provide the financial health for CHR-DB-B stock?

The financial health rating of CHORUS AVIATION INC (CHR-DB-B.CA) is 5 / 10.


Can you provide the expected EPS growth for CHR-DB-B stock?

The Earnings per Share (EPS) of CHORUS AVIATION INC (CHR-DB-B.CA) is expected to grow by 55.31% in the next year.